CARL (Carlsmed) Ending Cash Position: $46.34 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CARL Carlsmed Inc CARL
12 GF Score
Price $15.79
! 3 Warning Signs
View Full Analysis

What is Carlsmed Ending Cash Position?

Carlsmed CARL -1.56% 12 Ending Cash Position is $46.34 Mil as of Jun. 2026. GuruFocus rates CARL with a GF Score™ of 12/100. The stock has 3 warning signs investors should review.

Carlsmed's Ending Cash Position for the quarter that ended in Jun. 2026 was $46.34 Mil.

Carlsmed's quarterly Ending Cash Position declined from Dec. 2025 ($85.89 Mil) to Mar. 2026 ($73.12 Mil) and declined from Mar. 2026 ($73.12 Mil) to Jun. 2026 ($46.34 Mil).

Carlsmed's annual Ending Cash Position increased from Dec. 2023 ($7.37 Mil) to Dec. 2024 ($40.23 Mil) and increased from Dec. 2024 ($40.23 Mil) to Dec. 2025 ($85.89 Mil).

Carlsmed Ending Cash Position Related Terms

Carlsmed Ending Cash Position Historical Data

* Premium members only.

The historical data trend for Carlsmed's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Carlsmed Ending Cash Position Chart

Carlsmed Annual Data
Trend Dec23 Dec24 Dec25
Ending Cash Position
7.37 40.23 85.89

Carlsmed Quarterly Data
Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 33.57 115.47 85.89 73.12 46.34
CARL
12GF Score
Carlsmed Inc CARL
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Carlsmed Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Carlsmed's Ending Cash Position for the fiscal year that ended in Dec. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=40.225+45.668
=85.89

Carlsmed's Ending Cash Position for the quarter that ended in Jun. 2026 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=73.116+-26.772
=46.34

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of $46.34 Mil mean?
Carlsmed (CARL) has a Ending Cash Position of $46.34 Mil as of Jun. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Carlsmed and its competitors.
Is Carlsmed's Ending Cash Position too high?
Carlsmed's current Ending Cash Position is $46.34 Mil. Overall, Carlsmed has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Carlsmed's Ending Cash Position compare to CTEV and SPOK?
Carlsmed's Ending Cash Position of $46.34 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Healthcare Providers & Services company?
A good Ending Cash Position depends on the Healthcare Providers & Services industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Carlsmed and its competitors. Carlsmed's current Ending Cash Position is $46.34 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Carlsmed stock overvalued right now?
Carlsmed (CARL) has a current Ending Cash Position of $46.34 Mil. The current Ending Cash Position is $46.34 Mil. Carlsmed's overall GF Score™ is 12/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Carlsmed (CARL), the current Ending Cash Position is $46.34 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Carlsmed Business Description

Other Exchanges I82:Germany
Address 1800 Aston Avenue, Suite 100, Carlsbad, CA, USA, 92008
Carlsmed Inc is a commercial-stage medical technology company focused on developing AI-enabled personalized solutions for spine surgery. The company operates as a single operating and reportable segment engaged in the design, manufacture, and marketing of its Aprevo technology platform, which provides customized surgical planning and implants for lumbar and cervical spine fusion procedures, mainly sold to hospitals and ambulatory surgical centers.
12GF Score

Get the complete analysis for CARL

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$15.79
Price